Education
About Us
Working with TipRanks
Follow Us
Imunon (IMNN)
NASDAQ:IMNN
Total Valuation
Imunon has a market cap or net worth of $15.73M. The enterprise value is $11.79M.
Market Cap$15.73M
Enterprise Value$11.79M
Share Statistics
Imunon has 2,521,206 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,521,206
Owned by Insiders25.22%
Owned by Institutions0.11%
Financial Efficiency
Imunon’s return on equity (ROE) is -4.39 and return on invested capital (ROIC) is -355.38%.
Return on Equity (ROE)-4.39
Return on Assets (ROA)-1.92
Return on Invested Capital (ROIC)-355.38%
Return on Capital Employed (ROCE)-3.88
Revenue Per Employee0.00
Profits Per Employee-744.81K
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Imunon is ―. Imunon’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value2.96
Price to FCF―
Price to Operating Cash Flow-0.69
PEG Ratio―
Income Statement
In the last 12 months, Imunon had revenue of 0.00 and earned -18.62M in profits. Earnings per share was -21.10.
Revenue0.00
Gross Profit-718.12K
Operating Income-19.13M
Pretax Income-18.62M
Net Income-18.62M
EBITDA-17.98M
Earnings Per Share (EPS)-21.10
Cash Flow
In the last 12 months, operating cash flow was -14.27M and capital expenditures -294.77K, giving a free cash flow of -14.57M billion.
Operating Cash Flow-14.27M
Free Cash Flow-14.57M
Free Cash Flow per Share-5.78
Dividends & Yields
Imunon pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.45
52-Week Price Change-57.59%
50-Day Moving Average7.98
200-Day Moving Average11.27
Relative Strength Index (RSI)36.66
Average Volume (3m)348.56K
Important Dates
Imunon upcoming earnings date is Nov 17, 2025, TBA (Confirmed).
Last Earnings DateAug 5, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date―
Financial Position
Imunon as a current ratio of 1.67, with Debt / Equity ratio of 44.87%
Current Ratio1.67
Quick Ratio1.67
Debt to Market Cap0.00
Net Debt to EBITDA0.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Imunon has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Imunon EV to EBITDA ratio is -0.44, with an EV/FCF ratio of -0.42.
EV to Sales0.00
EV to EBITDA-0.44
EV to Free Cash Flow-0.42
EV to Operating Cash Flow-0.42
Balance Sheet
Imunon has $4.73M in cash and marketable securities with $1.19M in debt, giving a net cash position of -$3.54M billion.
Cash & Marketable Securities$4.73M
Total Debt$1.19M
Net Cash-$3.54M
Net Cash Per Share-$1.40
Tangible Book Value Per Share$4.81
Margins
Gross margin is -25.89%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-25.89%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Imunon is $210.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$210.00
Price Target Upside3365.35% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast45.96%